WADDELL & ASSOCIATES, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
WADDELL & ASSOCIATES, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$455,505
+10.6%
10,0420.0%0.07%
+11.7%
Q2 2023$412,023
+14.8%
10,0420.0%0.06%
+7.1%
Q1 2023$358,901
-5.4%
10,0420.0%0.06%
-12.5%
Q4 2022$379,286
-14.6%
10,0420.0%0.06%
-25.6%
Q3 2022$444,000
+19.4%
10,0420.0%0.09%
+13.2%
Q2 2022$372,000
-7.2%
10,0420.0%0.08%
+24.6%
Q2 2021$401,00010,0420.06%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
BB BIOTECH AG 7,725,000$627,038,00015.76%
Sicart Associates LLC 416,985$33,847,00014.30%
TANAKA CAPITAL MANAGEMENT INC 34,391$2,792,0008.42%
First Light Asset Management, LLC 611,162$49,608,0006.45%
DOWLING & YAHNKE LLC 675,478$54,829,0005.27%
Motley Fool Wealth Management, LLC 608,212$49,369,0003.18%
SECTOR GAMMA AS 233,714$18,971,0003.04%
TradeLink Capital LLC 5,200$422,0002.24%
Opus Point Partners Management, LLC 20,124$1,633,0002.21%
Dynamic Capital Management Ltd 6,096$495,0001.79%
View complete list of IONIS PHARMACEUTICALS INC shareholders